Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
Ayşe Elif Özdener-Poyraz, Malgorzata Slugocki, Julie Kalabalik-Hoganson, Jayoung Han Fairleigh Dickinson University, School of Pharmacy and Health Sciences, Department of Pharmacy Practice, Florham Park, NJ 07932, USACorrespondence: Ayşe Elif Özdener-PoyrazFairleigh Dickinson Unive...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/92042df1aef94f43bb66c0419b8c6887 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Ayşe Elif Özdener-Poyraz, Malgorzata Slugocki, Julie Kalabalik-Hoganson, Jayoung Han Fairleigh Dickinson University, School of Pharmacy and Health Sciences, Department of Pharmacy Practice, Florham Park, NJ 07932, USACorrespondence: Ayşe Elif Özdener-PoyrazFairleigh Dickinson University, School of Pharmacy and Health Sciences, Department of Pharmacy Practice, 230 Park Avenue, M-Sp1-01, Florham Park, NJ 07932, USATel +973-443-8211Email eozdener@fdu.eduAbstract: Pre-exposure prophylaxis (PrEP) against HIV infection with tenofovir/emtricitabine is proven to be effective yet uptake of this preventive measure has been difficult due to several barriers such as cost, access, and misinformation. Certain subpopulations are disproportionately affected by this problem. Several methods have been developed to close the gap in care. New antiretroviral treatment strategies are being investigated for safety and efficacy in preventing HIV infection.Keywords: pre-exposure prophylaxis, HIV prevention, PrEP uptake, medications |
|---|